List of molecules and drugs that target protein P00519

#	DrugDomain Data	DrugBank Accession	Name	Drug action	Affinity data	InChI Key	SMILES
1	P00519_DB00171	DB00171	ATP	inhibitor		ZKHQWZAMYRWXGA-KQYNXXCUSA-N	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
2	P00519_DB00619	DB00619	Imatinib	inhibitor	Ki(nM) = 13.0 IC50(nM) = 1.1 Kd(nM) = 1.0 EC50(nM) = 34.0	KTUFNOKKBVMGRW-UHFFFAOYSA-N	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
3	P00519_DB01254	DB01254	Dasatinib	multitarget	IC50(nM) = 0.138 Kd(nM) = 0.016 EC50(nM) = 0.04	ZBNZXTGUTAYRHI-UHFFFAOYSA-N	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
4	P00519_DB03878	DB03878	N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide	n/a		YWQVBESSYLICRX-UHFFFAOYSA-N	CC1=CC=C(NC(=O)C2=CC=CN=C2)C=C1NC1=NC=CC(=N1)C1=CC=CN=C1
5	P00519_DB04868	DB04868	Nilotinib	inhibitor	Ki(nM) = 1.0 IC50(nM) = 0.33 Kd(nM) = 3.6	HHZIURLSWUIHRB-UHFFFAOYSA-N	CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F
6	P00519_DB06616	DB06616	Bosutinib	inhibitor	IC50(nM) = 0.5 Kd(nM) = 0.029	UBPYILGKFZZVDX-UHFFFAOYSA-N	COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
7	P00519_DB07831	DB07831	2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	n/a		SHSORWZDEKFFLP-UHFFFAOYSA-N	CCCC1=CC=C(NC(=O)C2=CC=CC=C2NCC2=CNC(=O)C=C2)C=C1C(F)(F)F
8	P00519_DB08043	DB08043	1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA	n/a		DDDLGNOZDKDSEG-UHFFFAOYSA-N	FC(F)(F)C1=CC(NC(=O)NC2=CC=C(OC3=CC=NC=C3)C=C2)=CC=C1
9	P00519_DB08231	DB08231	Myristic acid	n/a		TUNFSRHWOTWDNC-UHFFFAOYSA-N	CCCCCCCCCCCCCC(O)=O
10	P00519_DB08339	DB08339	PD-166326	n/a	IC50(nM) = 2.8	ZIQFYVPVJZEOFS-UHFFFAOYSA-N	CN1C(=O)C(=CC2=CN=C(NC3=CC=CC(CO)=C3)N=C12)C1=C(Cl)C=CC=C1Cl
11	P00519_DB08350	DB08350	5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE	n/a	Ki(nM) = 20.0 IC50(nM) = 9.0	GYQRHHQPEMOLKH-UHFFFAOYSA-N	COC1=CC=CC=C1C1=CNC2=C1C=C(C=N2)C1=CC(=CN=C1)C(=O)N(C)C
12	P00519_DB08583	DB08583	2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide	n/a		INAGORZAOFUKOZ-UHFFFAOYSA-N	CCN1N=CC=C1C1=CNC2=NC=C(C=C12)C1=CC(C(=O)N(C)C)=C(N)C=C1
13	P00519_DB08896	DB08896	Regorafenib	inhibitor		FNHKPVJBJVTLMP-UHFFFAOYSA-N	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
14	P00519_DB08901	DB08901	Ponatinib	inhibitor	IC50(nM) = 0.3 Kd(nM) = 0.7 EC50(nM) = 0.05	PHXJVRSECIGDHY-UHFFFAOYSA-N	CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
15	P00519_DB12010	DB12010	Fostamatinib	inhibitor		GKDRMWXFWHEQQT-UHFFFAOYSA-N	COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
16	P00519_DB12267	DB12267	Brigatinib	inhibitor		AILRADAXUVEEIR-UHFFFAOYSA-N	COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
17	P00519_DB12323	DB12323	Radotinib	antagonist		DUPWHXBITIZIKZ-UHFFFAOYSA-N	CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=N3)=C2)=CC(=C1)C(F)(F)F
18	P00519_DB12597	DB12597	Asciminib	inhibitor		VOVZXURTCKPRDQ-CQSZACIVSA-N	O[C@@H]1CCN(C1)C1=C(C=C(C=N1)C(=O)NC1=CC=C(OC(F)(F)Cl)C=C1)C1=CC=NN1
19	P00519_DB14989	DB14989	Umbralisib	inhibitor		IUVCFHHAEHNCFT-INIZCTEOSA-N	CC(C)OC1=C(F)C=C(C=C1)C1=NN([C@@H](C)C2=C(C3=CC=CC(F)=C3)C(=O)C3=CC(F)=CC=C3O2)C2=C1C(N)=NC=N2